Press Releases Ypsomed Group
Burgdorf – Presence in the third largest diabetes market in Europe with the unique tubeless insulin pump mylife OmniPod.
As of the first quarter of 2014 Ypsomed is represented on the Italian market by its own subsidiary. It means that Ypsomed will now also have a presence in the third largest diabetes market in Europe with the unique tubeless insulin pump mylife OmniPod.
